BiotechTube
OD-OS

OD-OS

Teltow, Germany· Est.
od-os.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10.5M

Overview

OD-OS is a commercial-stage medical device company that has developed a proprietary, image-guided retinal laser system. Its Navilas® 577s platform combines a yellow laser with real-time eye-tracking and navigation software, transforming a manual procedure into a digitized, planned therapy aimed at enhancing precision, speed, and patient comfort. The system is commercially available and trusted by clinics in over 40 countries, positioning the company as a specialist in modernizing retinal laser care.

Ophthalmology

Technology Platform

Proprietary retina navigation and eye-tracking technology integrated with a 577nm yellow laser system for computer-assisted, image-guided retinal photocoagulation.

Funding History

2
Total raised:$10.5M
Series A$8M
Seed$2.5M

Opportunities

The global rise in diabetes-driven retinal disease creates a growing addressable market.
The shift towards subthreshold laser treatments and value-based care emphasizes the need for precise, documented therapies where Navilas® excels.
There is an opportunity to expand market share by displacing conventional lasers and integrating with digital diagnostic/AI platforms.

Risk Factors

Intense competition from large, established medical device companies with greater resources.
Concentration risk on a single product platform.
Potential reimbursement challenges for a premium-priced technology and the risk of treatment paradigms shifting away from laser therapy.

Competitive Landscape

OD-OS competes in the retinal laser market against major players like Zeiss, Topcon, Nidek, and Iridex. Its primary differentiation is its integrated eye-tracking and digital navigation system, which is less common among competitors. It positions itself as a high-precision, digital tool for modern retina practices, competing on technology and clinical workflow rather than cost.

More companies in Digital Health & Biotech SaaS →More companies in Germany →